tradingkey.logo

Drugmaker Novo Nordisk drops gender representation requirements in the US

ReutersMay 7, 2025 9:16 AM

- Obesity drugmaker Novo Nordisk NOVOb.CO said on Wednesday it would drop gender representation requirements for its U.S. business following executive orders by President Donald Trump to stop diversity, equity and inclusion initiatives.

"While Novo Nordisk maintains our global aspiration of a minimum 45% representation for each gender by the end of 2025, Novo Nordisk's operations in the U.S. will no longer participate in this global initiative due to evolving legal requirements," the company said in its first-quarter earnings statement.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI